FDA Documents of Boehringer Ingelheim Biopharmaceuticals (China) Ltd.
Boehringer Ingelheim Biopharmaceuticals (China) Ltd. is an organization that has been audited by the FDA 1 times between 2023 and 2023 across all 1 sites.
Documents
FDA 483 Boehringer Ingelheim Biopharmaceuticals (China) Ltd., Shanghai | 2023
Out-of-stock
Issued on: Jun 9, 2023
Human Drugs Form 483